Please login to the form below
Scott Gottlieb
This page shows the latest Scott Gottlieb news and features for those working in and with pharma, biotech and healthcare.
COVID-19 vaccines against Omicron may be fast-tracked
Scott Gottlieb, now working at Pfizer but previously commissioner of the US FDA agreed, saying there was “a reasonable degree of confidence in vaccine circles that [with] at least three ... Gottlieb agreed, saying the FDA was familiar with the mRNA
Latest news
-
Gilead reports remdesivir cuts risk of death in severe COVID-19 patients
Former US Food and Drug Administration (FDA) commissioner Scott Gottlieb also said that rigorous confirmation is needed to further support the data, tweeting that “this is very encouraging but needs to
-
UPDATED: Senate officially confirms Stephen Hahn as FDA commissioner
He was also backed by previous FDA commissioner Scott Gottlieb, who endorsed Sharpless as “an outstanding physician and scientist who is deeply committed to public health goals” who he hoped would
-
Mega-mergers dominate as buoyant markets lift biopharma
now former FDA commissioner Scott Gottlieb.
-
FDA will maintain the pace, vows Woodcock, but warns of skills gap
Top official unconcerned by dip in approval rate. The departure of Scott Gottlieb in April robbed the FDA of one of its most dynamic ever Commissioners, and industry observers have been ... Before Gottlieb departed earlier this year, he unveiled a new
-
Ex-FDA chief Gottlieb's quick move to pharma raises eyebrows
Will join Pfizer board. Just 83 days after leaving his Commissioner role at the FDA, Scott Gottlieb has joined the board of big pharma group Pfizer. ... We are fortunate to have D. Gottlieb join Pfizer’s Board of Directors,” said Pfizer executive
More from news
Approximately 5 fully matching, plus 46 partially matching documents found.
Latest Intelligence
-
Transforming clinical trials to accelerate drug development
For instance, former FDA commissioner Scott Gottlieb, highlighted that by “using more modern approaches to clinical trials, we can lower the cost of developing new drugs”.
-
20 for 2020 – Five pharma leaders to watch in 2020
He replaced Scott Gottlieb, who was popular with industry but resigned from the post unexpectedly last year, as well as stand-in Ned Sharpless who has now returned to his post
-
Will biosimilars ever catch on in the US?
In the early days of the Trump administration, then-FDA commissioner Scott Gottlieb made a point of clearing the way for even faster and more generic approvals, again with some apparent ... Based on those assumed savings, had all the FDA-approved
-
Encouraging signs in biomarker R&D
The timing of the withdrawal was ironic given that, in the same month, FDA Commissioner Scott Gottlieb highlighted ‘TMB as a potential biomarker for enriching clinical trials testing immunotherapies’. ... Harmonisation. Gottlieb has since resigned,
-
Streamlining clinical trials – why better data use is key
Dr Scott Gottlieb’s brief, energetic tenure as US FDA Commissioner is likely to shape agency oversight of the pharmaceutical industry for years to come, particularly in relation to clinical development. ... To embrace innovations like blockchain, as
More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.
Subscribe to our email news alerts
- Impacting Lives with Rare Disease Education
- Sandoz biosimilar receives EC approval to treat MS
- Pfizer’s Abrysvo RSV vaccine recommended by US CDC for infants
- CDC provides $262.5m to create national network for infectious diseases
- COVID-19 could be key in identifying viruses with pandemic potential
- Novo Nordisk Foundation commits €127m for new cell therapy facility
No results were found
PMHub
fox&cat
Fox&cat is an award-winning healthcare communications agency which creates inspirational campaigns and programmes that exceed expectations. Priding itself on delivering...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
